AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
7 oktober, 22:05
7 oktober, 22:05
AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251007123988/en/
7 oktober, 22:05
AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251007123988/en/
Boozt i Q3
Svensk ekonomi
Rapporter

Boozt i Q3
Svensk ekonomi
Rapporter

1 DAG %
Senast
Arjo
Idag, 17:20
Bennet miljonköper aktier i Arjo
OMX Stockholm 30
1 DAG %
Senast
2 741,08